Anhui Huaheng Biotechnology Co Ltd Class A 688639
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CN¥14.65
- Day Range
- CN¥14.25–15.07
- 52-Week Range
- CN¥14.25–43.60
- Bid/Ask
- CN¥15.01 / CN¥15.05
- Shares Outstanding
- 250.12M
- Market Cap
- CN¥3.75B
- Volume/Avg
- 6M / 6M
Key Statistics
- Price/Earnings (Normalized)
- 47.68
- Price/Sales
- 1.19
- Dividend Yield (Trailing)
- 1.09%
- Dividend Yield (Forward)
- 1.09%
- Dividend Payment Schedule
- May
- Total Yield
- 1.09%
Company Profile
Anhui Huaheng Biotechnology Co Ltd is engaged in the research and development, production and sales of bio-based products such as amino acids and other alanine products.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 2,252
- Website
- http://www.huahengbio.com
Valuation
|
Metric
|
688639
|
|---|---|
Price/Earnings (Normalized) | 47.68 |
Price/Book Value | 1.34 |
Price/Sales | 1.19 |
Price/Cash Flow | 22.26 |
Price/Earnings
688639
Financial Strength
|
Metric
|
688639
|
|---|---|
Quick Ratio | 0.62 |
Current Ratio | 1.14 |
Interest Coverage | 2.31 |
Quick Ratio
688639
Profitability
|
Metric
|
688639
|
|---|---|
Return on Assets (Normalized) | 1.26% |
Return on Equity (Normalized) | 2.78% |
Return on Invested Capital (Normalized) | 2.21% |
Return on Assets
688639
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|xZL&?s> | LOCK|s#lCX | $142B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|h>Z^<m | LOCK|Rfh< | $96B | |||
| Moderna Inc
MRNA
| LOCK|#>VRDrR | LOCK|!! | $89B | |||
| argenx SE ADR
ARGX
| LOCK|#<^xQZ> | LOCK|Sq# | $57B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|l^xC&T^ | LOCK|ZV | $43B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|^%&PR#n | LOCK|X!@qJ | $30B | |||
| Incyte Corp
INCY
| LOCK|>Rkc?! | LOCK|>? | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|$%#d>B | LOCK|@Ty | $22B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|s>JM!PW | LOCK|Z@nC | $22B | |||
| BridgeBio Pharma Inc
BBIO
| LOCK|YF&CrGg | LOCK|!CZ | $15B |
United States